OncoLog, Volume 58, Number 10, October 2013

Authors

Bryan Tutt, The University of Texas MD Anderson Cancer Center
Sunni Hosemann, The University of Texas MD Anderson Cancer Center
C. Wilcox, The University of Texas MD Anderson Cancer Center

Files

Contents

• Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer May replace Axillary Dissection for Some Patients: Sentinel lymph node dissection has become a standard staging tool for breast cancer patients with no clinical eveidence of disease in the lymph nodes
• INBRIEF: miR-200 MicroRNAs Slow Tumor Growth
• Compass: Resectable or Borderline Resectable Pancreatic Adenocarcinoma: Initial Treatment Options-Neoadjuvent chemoradiation may benefit patients with resectable disease
• HOUSE CALL: Hereditary Cancers: Genetic screening can give valuable information

Publication Date

10-1-2013

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Hunt, Kelly K.; Sood, Anil, M.D.; Le-Petross, Huong; Fleming, Jason B.; Varadhachary, Gauri R.; Crane, Christopher; Wolff, Robert A., 1957-; Rich, Thereasa; Sentinel Lymph Node Biopsy; Clinical Trials as Topic; Lymph Node Excision; Adenocarcinoma; Pancreatic Neoplasms; Neoadjuvant Therapy; Surgical Procedures, Operative; Neoplastic Syndromes, Hereditary; Genetic Testing; Breast Neoplasms.

Disciplines

History of Science, Technology, and Medicine | Oncology

Recommended Citation

Tutt, Bryan; Hosemann, Sunni; and Wilcox, C., "OncoLog, Volume 58, Number 10, October 2013" (2013). OncoLog MD Anderson's Report to Physicians (All issues). 241.
https://openworks.mdanderson.org/oncolog/241

Conditions Governing Access

Open